Esperion Therapeutics, Inc. · NASDAQ:ESPR
Koenig Sheldon L. disposed of 2,121,094 Esperion Therapeutics, Inc. shares (Form 4)
Traded Jul 13, 2026 · Filed Jul 13, 2026
On Jul 13, 2026, Koenig Sheldon L. (Director, President and CEO) disposed of 2,121,094 Esperion Therapeutics, Inc. shares, leaving 0 shares. Filed Jul 13, 2026 (Form 4).
- Disposed of
- 2,121,094 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | Disposition | 2,121,094 | 0 | Direct |
Source
Related
- Esperion Therapeutics, Inc.
- Koenig Sheldon L.
- Esperion Therapeutics, Inc. shareholders
- Form 4 · Koenig Sheldon L. · Jun 18, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026